A.P. inks pact with AstraZeneca to set up Genomic Solutions Centre in Amaravati
The centre to use next-generation sequencing, AI, and genomic technologies to facilitate early cancer detection and recommend personalised treatment based on a patient's genetic profile; as part of project, AI-enabled X-ray systems to be installed in government hospitals to ensure proper diagnosis
The Hindu reports that the State of Andhra Pradesh has signed a Memorandum of Understanding (MoU) with AstraZeneca India to establish an Integrated Genomic Solutions Centre in Amaravati. The initiative aims to create India's first integrated precision oncology research and treatment ecosystem, enabling personalised cancer diagnosis and treatment through advanced genomic technologies.
The centre will provide advanced genomic testing and biomarker analysis for patients with lung and breast cancers, using next-generation sequencing (NGS), artificial intelligence (AI), and genomic technologies to facilitate early cancer detection and recommend personalised treatment based on a patient's genetic profile.
Brief written by urgent.news from The Hindu's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
